Radiation therapy management in BRCA1/2 carriers diagnosed with early breast cancer: An international cohort study
Carlotta Becherini(Azienda Ospedaliero-Universitaria Careggi), Icro Meattini(Azienda Ospedaliero-Universitaria Careggi), R. Bernstein Molho, Laura De Marchis(Policlinico Umberto I), A. Di Meglio(Inserm), Eva Blondeaux(Ospedale Policlinico San Martino), Bela Mriňáková(Comenius University Bratislava), Alberta Ferrari(University of Pavia), C. Rousset-Jablonski(Centre de Recherche en Cancérologie de Lyon), Alexios Matikas(Karolinska University Hospital), Luca Visani(Azienda Ospedaliero-Universitaria Careggi), Rodrigo Sánchez-Bayona(Research Institute Hospital 12 de Octubre), Florentine Hilbers(Breast International Group), Adinda Baten(KU Leuven), A. Toss(Azienda Ospedaliero-Universitaria di Modena), Tiphaine Renaud(Institut Bergonié), Dione Aguilar y Méndez(Tecnológico de Monterrey), Elisa Agostinetto(Université Libre de Bruxelles), Jyoti Bajpai(Homi Bhabha National Institute), Virginia Delucchi(Azienda Ospedaliera S.Maria), Shelley Hwang(Duke University), Luca Boni(Azienda Ospedaliera S.Maria), W. Cui(Peter MacCallum Cancer Centre), F. Coussy(Institut Curie), K. Phillips(Peter MacCallum Cancer Centre), K. Pogoda(The Maria Sklodowska-Curie National Research Institute of Oncology), Fedro Alessandro Peccatori(European Institute of Oncology), A Kwong(Hong Kong Sanatorium and Hospital), Maria Vittoria Dieci(Istituto Oncologico Veneto), Hee Jeong Kim(Ulsan College), Deniz Can Güven(Centre de Recherche en Cancérologie de Lyon), Matteo Lambertini(Ospedale Policlinico San Martino), Fergus J. Couch(Mayo Clinic in Arizona), Minna K. Lee(Memorial Sloan Kettering Cancer Center), Ann H. Partridge(Dana-Farber Cancer Institute), Robert Fruscio(University of Milano-Bicocca), Judith Balmana(Vall d'Hebron Hospital Universitari), Mariya Rozenblit(Yale Cancer Center), Shani Paluch-Shimon(Hebrew University of Jerusalem), Stephanie M. Wong(Jewish General Hospital), Lucas Sanchez(Instituto Argentino de Diagnóstico y Tratamiento), Claudio Vernieri(Fondazione IRCCS Istituto Nazionale dei Tumori), Nadia Harbeck(LMU Klinikum), Jai Min Ryu(Samsung Medical Center), Halle C. F. Moore(Cleveland Clinic)
Cited by 0
Related Papers
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
|Annals of Oncology|2021|978
Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2021|558